近日，优龙机器人宣布获得谊安集团的战略投资，标志着其在医疗机器人领域的技术实力与市场前景获得行业龙头企业的高度认可。作为国内领先的麻醉和呼吸医疗设备制造商，谊安集团此次投资不仅为优龙机器人注入了资金支持，更将为其在医疗场景下的产品落地、渠道拓展及临床资源整合提供强大助力。优龙机器人专注于手术辅助与康复类智能机器人研发，其核心技术涵盖高精度运动控制、人机协作算法及AI驱动的感知系统。通过与谊安集团的深度协同，优龙有望加速其产品在手术室、ICU等关键医疗场景中的部署，推动国产高端医疗机器人从实验室走向规模化临床应用。此次战略合作也反映出中国医疗科技产业正加速融合创新——传统医疗器械企业与新兴人工智能公司携手，共同打造智能化、数字化的下一代医疗解决方案。未来，双方将在智能手术平台、远程诊疗系统及围术期管理等领域展开联合研发，进一步提升中国医疗机器人的全球竞争力。
Recently, YouLong Robotics announced it has secured strategic investment from AEONMED Group, signaling strong recognition from an industry leader of its technological capabilities and market potential in the medical robotics sector. As a leading Chinese manufacturer of anesthesia and respiratory care equipment, AEONMED’s investment not only provides financial support but also offers YouLong Robotics valuable access to clinical resources, distribution channels, and real-world medical deployment opportunities.YouLong Robotics specializes in developing intelligent robotic systems for surgical assistance and rehabilitation, with core competencies in high-precision motion control, human-robot collaboration algorithms, and AI-powered perception systems. Through deep collaboration with AEONMED, YouLong is poised to accelerate the adoption of its solutions in critical healthcare settings such as operating rooms and ICUs, helping bridge the gap between lab innovation and large-scale clinical application of domestically developed high-end medical robots.This strategic partnership also reflects a broader trend in China’s medtech industry—increasing convergence between traditional medical device companies and emerging AI-driven robotics firms to co-create next-generation, intelligent, and digital healthcare solutions. The two companies plan joint R&D initiatives in areas including smart surgical platforms, telemedicine systems, and perioperative care management, aiming to enhance the global competitiveness of Chinese medical robotics.
原创文章，作者：admin，如若转载，请注明出处：https://ktez.cn/5178.html